Please click here to log in with you RCPsych web account details; you will be redirected back to CPD Online.If you have forgotten your College web account details, you will be able to reset them here.
Please click here to log in if your institution has a subscription to CPD Online with Athens access.
Please click here to log in if you are subscribed through Medicom Netherlands.
If you having troubles signing in with the options above, please try this alternative login route.
About the authors
Related articles: BJPsych
Section 1: Indications for
(1.1) Section 1: Indications for ECT
(1.3) Depression: the Royal College of Psychiatrists
(1.4) Depression: NICE recommendations
(1.5) Other indications for ECT
(1.6) How is treatment resistance defined?
(1.7) How does treatment resistance affect response to ECT?
(1.8) ECT for neuropsychiatric disorders
(1.9) Clinical vignette: ECT for depression
(1.10) Reflection: model answer
(1.11) Section 1: Recap
(1.12) Section 1:
Section 2: The prescribing
(2.1) Section 2: The prescribing cycle
(2.2) The prescribing cycle
(2.3) Initial electrode placement
(2.4) Initial electrode placement
(2.5) Factors affecting the decision on electrode placement
(2.6) Frequency and number of treatments
(2.7) Number of treatments
(2.8) Number of treatments
(2.9) When does ECT lack efficacy in a particular patient?
(2.10) Section 2: Recap
(2.11) Section 2:
Section 3: Informed
(3.1) Section 3: Informed consent
(3.2) Giving relevant information about ECT
(3.3) Capacity and consent
(3.4) The process of consent
(3.5) Likely benefits and risks
(3.6) Cognitive adverse effects of ECT
(3.7) Cognitive adverse effects of ECT
(3.8) The tolerability of a course of ECT
(3.9) Section 3: Recap
(3.10) Section 3: